RHOA and diabetes mellitus: In a clinical study of healthy, pre-diabetes, diabetes, and diabetic patients with CVD (DM-CVD) subjects (n = 10-11 per group), DM-CVD neutrophils exhibited a distinct impedance signature and pro-inflammatory transcriptomic profile marked by cytoskeletal dysregulation and altered RhoA signaling.